AGP Executive Report
Last update: 4 hours agoHemp/CBD Policy Fight: CMS chief Mehmet Oz urged the Senate to keep a continuing-resolution delay on the federal hemp THC ban (pushing the start from Nov. 12 to Dec. 11), arguing it protects Medicare seniors using hemp-derived CBD for chronic pain, cancer pain, and seizures—while drug-safety advocates and Sen. Ted Budd push to remove the delay. FDA Child-Safety Warning: The FDA says delta-8 THC gummies and similar “looks-like-candy” products are being marketed with child-appealing packaging and labeling; poison center data logged 2,362 delta-8 exposure cases (41% under 18) with many unintentional ingestions by children. Medical Cannabis Access in Court: A Florida paramedic fired after testing positive for medical marijuana is set to appeal after a state appeals court said his card doesn’t trigger accommodation under his bargaining agreement. Public Health Signal: A CDC report finds more frequent marijuana users are showing up in ERs with cannabinoid hyperemesis syndrome, with nearly 200,000 ER visits linked to the condition from Jan. 2023 to May 2026. State Legal Updates: New York expanded legal cannabis sales to approved farmers markets and pop-ups via licensed microbusinesses and dispensaries. Local Enforcement/Use: A South Dakota AG said officers were justified in a July shooting after the suspect tested positive for cannabinoids; separate reporting also highlights ongoing cannabis-related legal disputes and enforcement.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
